HCA Healthcare Inc

HCA Healthcare Inc

HCA

Get informed when a big investor buys or sells

+ Follow
Market Cap$83.98B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
HCA Healthcare IncHCA Healthcare Inc12.60.78%-1.1-

Earnings Call Q1 2026

April 24, 2026 - AI Summary

Quarterly Performance: HCA Healthcare achieved a 4.3% increase in revenue and approximately a 2% rise in adjusted EBITDA year-over-year for Q1 2026. Diluted earnings per share, as adjusted, improved by about 11% compared to the same period last year, highlighting resilience amid a challenging volume environment.
Volume and Weather Impact: Respiratory-related admissions decreased by 42% and emergency room visits dropped by 32% compared to the prior year. Additionally, a winter storm negatively affected volumes, contributing an estimated $180 million in adjusted EBITDA impact, reflecting a temporal challenge rather than a long-term trend.
Payer Mix Dynamics: The company observed a shift in payer mix with a 15% decline in same facility exchange equivalent adjusted admissions and a 16% increase in uninsured equivalent admissions. HCA's earlier expectations regarding volume declines from health insurance exchanges appear to be aligning with actual performance, indicating ongoing challenges from the exchange environment.

Exclusive for Stockcircle Pro members

Sign upSign Up
$526.20

Target Price by Analysts

45.4% upsideHCA Healthcare Target Price DetailsTarget Price
$338.81

Current Fair Value

6.4% downside

Overvalued by 6.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$83.98 Billion
Enterprise Value$95.74 Billion
Dividend Yield$2.94 (0.78%)
Earnings per Share$28.62
Beta1.19
Outstanding Shares226,653,000

Return

Return on EquityNaN%ROE
Return on Assets0.28%
Return on Invested Capital6.54%

Valuation & Multiples

P/E Ratio12.63P/E Ratio
PEG2033.17PEG
Price to Sales1.07Price to Sales
Price to Book Ratio0.87Price to Book Ratio
Enterprise Value to Revenue1.25
Enterprise Value to EBIT19
Enterprise Value to Net Income365
Total Debt to Enterprise0.13
Debt to Equity-Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
April 24, 2026
EPS Estimate
$7.12
Average shareholder expectation
Revenue Estimate
$19.09 B
Average shareholder expectation

Next Earnings Call

Expected Date
July 24, 2026
EPS Estimate
$7.37
Average shareholder expectation
Revenue Estimate
$19.35 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.9089 15.07%
Total Calls998,031 30.85%
Total Puts907,113 40.68%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %56.56% 2.54%
Total Invested$61.70B 3.10%
Investors Holding1,460 11.00%

ESG Score

No data

About HCA Healthcare Inc

280,000 employees
CEO: Samuel Hazen

Nashville-based HCA Healthcare is one of the nation's leading providers of healthcare services comprising more than 2,000 sites of care, including 187 hospitals, surgery centers, freestanding ERs, urgent care centers, and physician clini...

Relevant Senate Committees

Finance

This is one of the most powerful committees for HCA. It controls taxation (corporate tax policy directly impacts HCA's profitability) and entitlement spending, specifically overseeing Medicare and Medicaid financing, reimbursement rates, and broader healthcare spending, which are crucial revenue streams for HCA.

Appropriations

This committee directly allocates discretionary federal spending. Its subcommittees determine the precise funding for federal healthcare programs (e.g., specific allocations to HHS for Medicare/Medicaid), which are massive revenue sources for HCA Healthcare.

Health, Education, Labor, and Pensions

This committee directly impacts HCA. Its jurisdiction over health policy (FDA, NIH), labor laws (minimum wage, union regulations, workforce costs for a major employer), and pension rules directly regulates HCA's operational costs, patient care standards, and business environment.

Judiciary

This committee's oversight of antitrust laws and the DOJ is critically relevant for HCA Healthcare. As a large hospital system, HCA is frequently involved in mergers and acquisitions, making antitrust scrutiny a direct and significant factor in its growth strategy and legal environment.